These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Brochu E; Lacasse S; Moreau C; Lebel M; Kingma I; Grose JH; Larivière R Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266 [TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner. Trenkner J; Priem F; Bauer C; Neumayer HH; Raschak M; Hocher B Clin Sci (Lond); 2002 Aug; 103 Suppl 48():385S-388S. PubMed ID: 12193128 [TBL] [Abstract][Full Text] [Related]
5. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure. Francis B; Winaver J; Karram T; Hoffman A; Abassi Z J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359 [TBL] [Abstract][Full Text] [Related]
6. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats. Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure. Brochu E; Lacasse S; Larivière R; Kingma I; Grose JH; Lebel M J Am Soc Nephrol; 1999 Jul; 10(7):1440-6. PubMed ID: 10405199 [TBL] [Abstract][Full Text] [Related]
8. ETA receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat. Pollock DM; Polakowski JS J Am Soc Nephrol; 1997 Jul; 8(7):1054-60. PubMed ID: 9219154 [TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system blockade alone or combined with ET Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881 [TBL] [Abstract][Full Text] [Related]
10. Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats. Shimizu T; Hata S; Kuroda T; Mihara S; Fujimoto M Eur J Pharmacol; 1999 Sep; 381(1):39-49. PubMed ID: 10528132 [TBL] [Abstract][Full Text] [Related]
11. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Benigni A; Zola C; Corna D; Orisio S; Facchinetti D; Benati L; Remuzzi G Am J Kidney Dis; 1996 Mar; 27(3):416-23. PubMed ID: 8604712 [TBL] [Abstract][Full Text] [Related]
12. Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats. Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P J Cardiovasc Pharmacol; 2000 Oct; 36(4):428-37. PubMed ID: 11026642 [TBL] [Abstract][Full Text] [Related]
13. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Yard B; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P Transplantation; 1999 Sep; 68(6):739-46. PubMed ID: 10515373 [TBL] [Abstract][Full Text] [Related]
14. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006 [TBL] [Abstract][Full Text] [Related]
15. Low NaCl intake elevates renal medullary endothelin-1 and endothelin A (ETA) receptor mRNA but not the sensitivity of renal Na+ excretion to ETA receptor blockade in rats. Klinger F; Grimm R; Steinbach A; Tanneberger M; Kunert-Keil C; Rettig R; Grisk O Acta Physiol (Oxf); 2008 Mar; 192(3):429-42. PubMed ID: 17892519 [TBL] [Abstract][Full Text] [Related]
16. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Allcock GH; Venema RC; Pollock DM Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985 [TBL] [Abstract][Full Text] [Related]
17. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats. Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531 [TBL] [Abstract][Full Text] [Related]
18. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure. Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302 [TBL] [Abstract][Full Text] [Related]
19. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Dumont Y; D'Amours M; Lebel M; Larivière R Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268 [TBL] [Abstract][Full Text] [Related]
20. Improved recovery following posttransplant acute renal failure in rat renal isografts with an oral endothelin-A receptor antagonist. Braun C; Vetter S; Conzelmann T; Schaub M; Kirchengast M; van der Woude FJ; Rohmeiss P Exp Nephrol; 2000; 8(4-5):283-90. PubMed ID: 10940728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]